Kestrel Group Stock Today
| KG Stock | 8.49 0.19 2.19% |
PerformanceWeakest
| Odds Of DistressFair
|
Kestrel is trading at 8.49 as of the 11th of January 2026. This is a 2.19% down since the beginning of the trading day. The stock's lowest day price was 8.31. Kestrel has 47 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. Kestrel symbol was changed from MHLD on 28th of May 2025. The performance scores are derived for the period starting the 13th of October 2025 and ending today, the 11th of January 2026. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 25th of June 1998 | Category Financial Services | Classification Health Care |
Kestrel is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 7.74 M outstanding shares of which 138 K shares are now sold short in the market by investors with about 4.78 days to cover all shorted shares. More on Kestrel Group
Moving against Kestrel Stock
Kestrel Stock Highlights
| Older Symbol | MHLD | |||||||||||||||||||||||||||||||||||||||||||||
| CEO Director | Bradford Ledbetter | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Financial Services, NASDAQ Composite, Health Care, Pharmaceuticals, Pharmaceutical Products, Health Care (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsKestrel can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Kestrel's financial leverage. It provides some insight into what part of Kestrel's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
Kestrel Group (KG) is traded on NASDAQ Exchange in USA and employs 4 people. Kestrel Group was previously known as MHLD Old and was traded on NASDAQ Exchange under the symbol MHLD. Kestrel is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a market capitalization of 65.73 M. Kestrel Group is active under Pharmaceuticals sector as part of Health Care industry. The entity has 7.74 M outstanding shares of which 138 K shares are now sold short in the market by investors with about 4.78 days to cover all shorted shares.
Kestrel Group reports about 545.31 M in cash with (67.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.58.
Check Kestrel Probability Of Bankruptcy
Ownership AllocationThe majority of Kestrel outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in Kestrel Group to benefit from reduced commissions. Consequently, institutional holders are subject to a different set of regulations than regular investors in Kestrel Group. Please pay attention to any change in the institutional holdings of Kestrel as this could imply that something significant has changed or is about to change at the company.
Check Kestrel Ownership Details
Kestrel Historical Income Statement
Kestrel Stock Against Markets
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kestrel Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kestrel. If investors know Kestrel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kestrel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 8.73 | Revenue Per Share 3.446 | Quarterly Revenue Growth 22.198 |
The market value of Kestrel Group is measured differently than its book value, which is the value of Kestrel that is recorded on the company's balance sheet. Investors also form their own opinion of Kestrel's value that differs from its market value or its book value, called intrinsic value, which is Kestrel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kestrel's market value can be influenced by many factors that don't directly affect Kestrel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kestrel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kestrel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kestrel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.